 |
|
leflunomide
A derivative of isoxazole used for its immunosuppressive and anti-inflammatory properties. As a prodrug, leflunomide is converted to an active metabolite, A77 1726, which blocks dihydroorotate dehydrogenase, a key enzyme of de novo pyrimidine synthesis, thereby preventing the expansion of activated T lymphocytes. This agent also inhibits various protein tyrosine kinases, such as protein kinase C (PKC), thereby inhibiting cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | SU101 | | | | US brand name: | | Arava | | | | Chemical structure name: | | 4-Isoxazolecarboxamide, 5-Methyl-N-(4-(trifluoromethyl)phenyl)- | | |
|
|
